BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22162584)

  • 21. Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.
    Gonçalves AC; Alves R; Baldeiras I; Cortesão E; Carda JP; Branco CC; Oliveiros B; Loureiro L; Pereira A; Nascimento Costa JM; Sarmento-Ribeiro AB; Mota-Vieira L
    Mol Carcinog; 2017 Jan; 56(1):130-148. PubMed ID: 26950655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).
    Freedman RA; Seisler DK; Foster JC; Sloan JA; Lafky JM; Kimmick GG; Hurria A; Cohen HJ; Winer EP; Hudis CA; Partridge AH; Carey LA; Jatoi A; Klepin HD; Citron M; Berry DA; Shulman LN; Buzdar AU; Suman VJ; Muss HB
    Breast Cancer Res Treat; 2017 Jan; 161(2):363-373. PubMed ID: 27866278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study.
    Joelsson J; Wästerlid T; Rosenquist R; Jakobsen LH; El-Galaly TC; Smedby KE; Eloranta S
    Blood Adv; 2022 Apr; 6(8):2657-2666. PubMed ID: 35042239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
    Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
    Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia.
    Hasle H; Olsen JH
    Br J Haematol; 1997 Apr; 97(1):127-31. PubMed ID: 9136952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study.
    Takaoka K; Koya J; Yoshimi A; Toya T; Kobayashi T; Nannya Y; Nakazaki K; Arai S; Ueno H; Usuki K; Yamashita T; Imanishi D; Sato S; Suzuki K; Harada H; Manabe A; Hayashi Y; Miyazaki Y; Kurokawa M
    Leuk Lymphoma; 2020 Jul; 61(7):1688-1694. PubMed ID: 32157945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
    Owattanapanich W; Herzig J; Jahn N; Panina E; Ruchutrakool T; Kungwankiattichai S; Issaragrisil S; Döhner H; Döhner K
    Ann Hematol; 2021 Aug; 100(8):1983-1993. PubMed ID: 33839881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders.
    Schratz KE; Gaysinskaya V; Cosner ZL; DeBoy EA; Xiang Z; Kasch-Semenza L; Florea L; Shah PD; Armanios M
    J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34343137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
    Sébert M; Passet M; Raimbault A; Rahmé R; Raffoux E; Sicre de Fontbrune F; Cerrano M; Quentin S; Vasquez N; Da Costa M; Boissel N; Dombret H; Peffault de Latour R; Socié G; Itzykson R; Fenaux P; Soulier J; Adès L; Clappier E
    Blood; 2019 Oct; 134(17):1441-1444. PubMed ID: 31484648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial myelodysplastic syndrome/acute myeloid leukemia.
    Churpek JE
    Best Pract Res Clin Haematol; 2017 Dec; 30(4):287-289. PubMed ID: 29156196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of secondary myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in patients with ovarian or breast cancer in a real-world setting in the United States.
    Shenolikar R; Durden E; Meyer N; Lenhart G; Moore K
    Gynecol Oncol; 2018 Nov; 151(2):190-195. PubMed ID: 30268525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.
    Poynter JN; Richardson M; Blair CK; Roesler MA; Hirsch BA; Nguyen P; Cioc A; Warlick E; Cerhan JR; Ross JA
    Cancer Epidemiol; 2016 Feb; 40():134-40. PubMed ID: 26720913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms.
    Badar T; Chlon T
    Curr Hematol Malig Rep; 2022 Oct; 17(5):113-120. PubMed ID: 35781188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Banaszak LG; Cabral PL; Smith-Simmer K; Hassan A; Brunner M; Fallon M; Shoger K; Lovrien L; Golner D; Zurbriggen L; Mattison R; Gahvari Z; Hall A; Nadiminti K; Reinig E; Churpek JE
    JCO Precis Oncol; 2024 Jun; 8():e2300518. PubMed ID: 38848520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.
    Gruschkus SK; Lairson D; Dunn JK; Risser J; Du XL
    Cancer; 2010 Nov; 116(22):5279-89. PubMed ID: 20665502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
    Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K
    PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.
    Nardi V; Winkfield KM; Ok CY; Niemierko A; Kluk MJ; Attar EC; Garcia-Manero G; Wang SA; Hasserjian RP
    J Clin Oncol; 2012 Jul; 30(19):2340-7. PubMed ID: 22585703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coffee and green tea consumption and subsequent risk of acute myeloid leukemia and myelodysplastic syndromes in Japan.
    Ugai T; Matsuo K; Sawada N; Iwasaki M; Yamaji T; Shimazu T; Goto A; Inoue M; Kanda Y; Tsugane S;
    Int J Cancer; 2018 Mar; 142(6):1130-1138. PubMed ID: 29076523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.